ÓªÒµ×Éѯ
Öйú£º
Email: marketing@medicilon.com.cn
ÓªÒµ×ÉѯרÏߣº400-780-8018
£¨½öÏÞЧÀÍ×Éѯ£¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©
´¨É³×ܲ¿µç»°: +86 (21) 5859-1500
ÍâÑó£º
+1(781)535-1428(U.S.)
0044 7790 816 954 (Europe)
Email:marketing@medicilon.com




×ðÁú¿Ê±¼´½«¼ÓÈë2023ÄêÃÀ¹ú°©Ö¢Ñо¿Ð»áÄê»á(American Association for Cancer Research Annual Meeting, AACRÄê»á)¡£±¾½ìÄê»á½«º¸ÇÐí¶àÈÈÃÅ»°Ì⣬°üÀ¨ÃâÒßÖÎÁÆ¡¢»ùÒò±à¼¡¢Ò©ÎïÑо¿ºÍÁÙ´²ÊÔÑéµÈÁìÓòµÄ×îÐÂÏ£ÍûºÍÇ÷ÊÆ¡£×ðÁú¿Ê±Ò©ÀíҩЧÓëÉúÎﲿ¸±×ܲõ˾²²©Ê¿Óë×ðÁú¿Ê±¹ú¼ÊÑз¢Ð§ÀͲ¿Ö´Ðи±×ܲô÷ѧ¶«²©Ê¿½«Ðͬ×ðÁú¿Ê±ÃÀ¹úÍŶÓһͬÁÁÏàAACRÄê»áÏÖ³¡(Orange County Convention Center, Orlando, FL)£¬ÌṩЧÀÍչʾºÍ½»Á÷ʱ»ú£¬×ðÁú¿Ê±Õ¹Î»ºÅ3047£¬ÆÚ´ýÓëÄúµÄÎîÃæ£¡
ʱ¼ä | 4.14-4.19, 2023
µØµã | ·ðÂÞÀï´ïÖݰÂÀ¼¶à°ÂÀ¼ÖÎÏØ¾Û»áÖÐÐÄ
×ðÁú¿Ê±Õ¹Î»ºÅ | #3047
ÃÀ¹ú°©Ö¢Ñо¿Ð»á(AACR)ÊǵÚÒ»¸öÒ²ÊÇ×î´óµÄÖÂÁ¦ÓÚ¼ÓËÙÕ÷·þ°©Ö¢µÄ°©Ö¢Ñо¿×éÖ¯¡£AACRÓÚ1907Äê5ÔÂ7ÈÕÔÚ»ªÊ¢¶ÙÌØÇø½¨É裬ÓÉ11Ãû¶ÔÑо¿¸ÐÐËȤµÄÒ½ÉúºÍ¿ÆÑ§¼Ò×é³É£¬Ö¼ÔÚ¡°½øÒ»³ÌÐò²éºÍÈö²¥°©Ö¢ÖªÊ¶¡±¡£2023 AACRÄê»áÖ÷Ì⣺Advancing the Frontiers of Cancer Science and Medicine£¨Íƽø°©Ö¢¿ÆÑ§ºÍҽѧµÄÇ°ÑØ£©¡£
ÿÄêAACRÄê»áÉ϶¼»áÐû²¼°©Ö¢ÖÎÁÆ×îÐÂÏ£Íû¡£½ñÄ꽫ÔÚ·ðÂÞÀï´ïÖݰÂÀ¼¶àµÄ°ÂÀ¼ÖÎÏØ¾Û»áÖÐÐÄ(4ÔÂ16ÈÕÖÁ19ÈÕÕ¹³ö)ÓëÀ´×ÔÌìϸ÷µØµÄ2Íò¶àÃû¿ÆÑ§¼ÒºÍÆäËû°©Ö¢×¨ÒµÈËÊ¿ÅöÃæ¡£ÕâЩÓë»áÕßÊÇʵÑéÊÒ¿ÆÑ§¼ÒºÍÁÙ´²Ñо¿Ö°Ô±£¬ËûÃÇרעÓÚ°©Ö¢Ñо¿µÄ¸÷¸ö·½Ã棬°üÀ¨ÊµÑéÖÎÁÆÑ§¡¢·Ö×Ó°ÐÏòÖÎÁÆ¡¢»¯Ñ§¡¢·Ö×ÓÉúÎïѧºÍÒÅ´«Ñ§¡¢ÃâÒßѧºÍÃâÒßÖÎÁÆ¡¢Ö×ÁöÉúÎïѧ¡¢²¡¶¾Ñ§¡¢¶¾Àíѧ¡¢Ô¤·ÀÒÔ¼°ÁÙ´²ºÍת»¯Ñо¿¡£

AACRÕ¹ÌüλÓÚ°ÂÀ¼ÖÎÏØ¾Û»áÖÐÐÄÎ÷Â¥2²ãµÄB¹ÝºÍD¹Ý£¬×ðÁú¿Ê±Õ¹Ì¨Î»ÓÚ×¢²ą́Èë¿Ú´¦£¬Õ¹Î»ºÅ3047¡£
´Ë´ÎAACR¾Û»áÉÏ×ðÁú¿Ê±´øÀ´2Õź£±¨£¬Õ¹Ê¾×ðÁú¿Ê±ADCºÍPROTACƽ̨µÄǿʢʵÁ¦£º"Evaluation of The Efficacy of ADC Drugs In Vitro & Vivo" ºÍ "Efficacy Studies and PK/PD of PROTAC Drugs In Vitro &Vivo"
×ðÁú¿Ê±ÔÚADCµÄÁÙ´²Ç°Ò»Ì廯Ñо¿¼Æ»®Öƶ©ÖÐÓë¿Í»§ÉîÈë½»Á÷£¬¿ÆÑÐÖ÷¸É½«Ã¿Ò»¸ö°¸ÀýµÄÌØµãÓë¶àÄêʵսÂÄÀúºÍÊÖÒÕ»ýÀÛÏàÁ¬Ïµ£¬ÉóÉ÷µØ½«ÓÅÖÊʵÑ鼯»®ÓëЧ¹ûÌá½»µ½¿Í»§ÊÖÉÏ¡£×ðÁú¿Ê±¿ÉÒÔΪ¿Í»§ÌṩADC Payloads ºÏ³É¡¢ADC ҩЧѧÆÀ¼Û¡¢ADC Ò©´ú¶¯Á¦Ñ§ÆÀ¼ÛºÍADC Çå¾²ÐÔÆÀ¼ÛµÈЧÀÍ¡£×èÖ¹2022Äê⣬×ðÁú¿Ê±ÒÑÀÖ³ÉÖúÁ¦13¸öADCÒ©Îï»ñÅúÁÙ´²£¬²¢ÓÐ10¶à¸öADCÏîÄ¿ÔÚÑС£×èÖ¹ÏÖÔÚ£¬×ðÁú¿Ê±³Ð½ÓµÄINDÉ걨ÀàÉúÎïÒ©´óÏîÄ¿ÒѾ100¶àÏ°üÀ¨µ¥¿¹¡¢Ë«¿¹¡¢¶à¿¹¡¢ADC¡¢²¡¶¾ÒßÃçºÍÈÚºÏÂѰ׵ȡ£
×ðÁú¿Ê±PROTACÒ©Îï·¢Ã÷ÊÖÒÕÆ½Ì¨»ã×ÜÁËÄ¿½ñÊ¢ÐеÄÈÈÃŵİбêÂѰ×ÅäÌ壻½¨ÉèÁËÆÕ±éµÄÈÈÃŰÐÏòÂѰ׸߶ÈÇ׺ÍÁ¦Ð¡·Ö×Ó¼°Ð¡·Ö×ÓÆ¬¶Ï»¯ºÏÎï¿â£¨TPSM£©£¬ÆÕ±éµÄE3ÅþÁ¬Ã¸£¬¸ß¶ÈÇ׺ÍÁ¦µÄС·Ö×Ó¼°Ð¡·Ö×ÓÆ¬¶Ï£¨E3SM£©£»½¨ÉèÁËlinkerϵͳ,°üÀ¨ÍøÂç´ó×Ú¾ßÓÐÆÕ±é¶àÑùÐÔµÄË«¹ÙÄÜÍÅÅþÁ¬Ì壨BF-Linker£©¡£ÕâЩ»ýÀ۵ϝºÏÎï¿â¿ÉÒÔ×ÊÖú¿ìËÙ¸ßЧµÄºÏ³É´ó×ڸ߻îÐÔPROTACË«ÌØÒìÐÔС·Ö×Ó£¬¼«´óµØÌá¸ß½ÓÄÉPROTACÊÖÒÕ¾ÙÐеÄÒ©ÎïÑз¢Àú³Ì¡£³ýÁË¿ìËٺϳÉÖ®Í⣬ÎÒÃÇͬʱ½¨ÉèºÍÍêÉÆµÄPROTACÉúÎïɸѡÓë²âÊÔÆ½Ì¨£¬ºóÐøÉú³¤¹âÁÙ´²Ç°ËùÓн׶Ρ£×èÖ¹2022Äê⣬×ðÁú¿Ê±ÒÑÀÖ³ÉÖúÁ¦3¸öPROTACÒ©Îï»ñÅúÁÙ´²£¬²¢ÓÐ20¶à¸öPROTACÏîÄ¿ÔÚÑС£
Ïà¹ØÐÂÎÅʱ¼ä£º2019Äê3ÔÂ29ÈÕ-4ÔÂ3ÈÕ
ËùÔÚ£ºÃÀ¹ú?×ôÖÎÑÇÖÝ